Forschungsallianz Immunmedizin

We are creating innovative immunotherapies for major common diseases through a scientific paradigm shift that will lead to the development of new diagnostic, preventive and therapeutic tools for life-threatening diseases.

We are curing infections, cancer and autoimmune diseases to improve patient care and quality of life.

 An improved, holistic understanding of the complex, molecular mechanisms of the immune system is the basis for the development of innovative, targeted therapies for immunological diseases.

The Forschungsallianz Immunmedizin networks complementary strategies at the University sites Erlangen-Nürnberg, Regensburg and Würzburg and develops synergistic key areas to strengthen immunomedicine at the highest level in northern and eastern Bavaria.